1. Nelson KB, Ellenberg JH. Predictors of low and very low birth weight and the relation of these to cerebral palsy. JAMA1985;254:1473-1479.
2.
2. Nelson KB, Ellenberg JH. Antecedants of cerebral palsy: Multivariate analysis of risk. N Engl J Med1986;315:81-86.
3.
3. Cummins SK, Nelson KB, Grether JK, Velie EM. Cerebral palsy in four northern California counties births 1983-1985. Pediatr1993;123:230-237.
4.
4. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants?Pediatrics1995;95:263-269.
5.
5. Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and the risk of spastic cerebral palsy in premature children born to women without pre-eclampsia. Am J Obstet Gynecol2000;183:717-725.
6.
6. Mittendorf R, Covert R, Bowman J, Khoshnood B, Lee KS, Siegler M. Is tocolytic magnesium sulfate associated with increased total paediatric mortality?Lancet1997;350:1517-1518.
7.
7. Kimberlin DF, Hauth JC, Goldenoerg FL, et al. The effect of maternal magneisum sulfate on neonatal morbidity in 1000 gram infants. Am J Perinatol1998;15:635-641.
8.
8. Farkaub LJ, Thorp JA, Jones PG, et al. Antenatal magnesium exposure and neonatal demise. Am J Obstet Gynecol2001;185:869-869.
9.
9. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol1994;170:1458-1466.
10.
10. Marks KA, Mallard CE, Roberts I, Williams CE, Gluckman PD, Edward AD. Nitric oxide synthease inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr Res1996;40:185-191.
11.
11. Marks KA, Mallard CE, Roberts I, Williams CE, Gluckman PD, Edwards AD. Nitric oxide synthease inhibition and delayed cerebral injury after severe cerebral ischemia in fetal sheep. Pediatr Res1999;46:8-13.